Treatment Intermittent Periods Based on ctDNA-MRD（Circulating Tumor DNA-minimal Residual Disease） Status in Advanced HER2-Positive Breast Cancer
Clinical trial NCT07132502 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07132502
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-08-25
- Primary completion
- 2027-07-08
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.